The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.

Taxanes, including docetaxel (DOCE), are severely neurotoxic, causing disabling peripheral neuropathy. Co-treatment with neuroprotective agents has been proposed to prevent or reverse this. Besides its hemopoietic effects, erythropoietin (EPO) has neuroprotective and neurotrophic properties and when...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Cervellini, I, Bello, E, Frapolli, R, Porretta-Serapiglia, C, Oggioni, N, Canta, A, Lombardi, R, Camozzi, F, Roglio, I, Melcangi, R, D'incalci, M, Lauria, G, Ghezzi, P, Cavaletti, G, Bianchi, R
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2010

Παρόμοια τεκμήρια

Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model.
ανά: Roglio, I, κ.ά.
Έκδοση: (2009)

Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy.
ανά: Bianchi, R, κ.ά.
Έκδοση: (2012)

Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies.
ανά: Chiorazzi, A, κ.ά.
Έκδοση: (2009)

Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies
ανά: Alessia Chiorazzi, κ.ά.
Έκδοση: (2009-08-01)

Erythropoietin does not affect TNF and IL-6 production directly.
ανά: Cervellini, I, κ.ά.
Έκδοση: (2013)

Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
ανά: Cervellini, I, κ.ά.
Έκδοση: (2013)

Securing The Border: Examining The Interagency Border Control Management in Kedah and Perlis (S/O 13762)
ανά: Ahmad Apandi, Laila Suriya, κ.ά.
Έκδοση: (2021)

Neutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy.
ανά: Michela M Taiana, κ.ά.
Έκδοση: (2014-01-01)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
ανά: T. Laragione, κ.ά.
Έκδοση: (2005-01-01)

Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites
ανά: Valeria Bellini, κ.ά.
Έκδοση: (2020-12-01)

Erythropoietin: still on the neuroprotection road
ανά: Nelvys Subirós, κ.ά.
Έκδοση: (2012-05-01)

NEUROPROTECTIVE EFFECTS OF ERYTHROPOIETIN: OPPORTUNITIES, PROSPECTS AND REALITY (REVIEW)
ανά: I. Kladova, κ.ά.
Έκδοση: (2014-09-01)

Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor.
ανά: Cervellini, I, κ.ά.
Έκδοση: (2013)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
ανά: Carolina Castillo Hernández, κ.ά.
Έκδοση: (2017-01-01)

Neuroprotective effects of erythropoietin in acute ischemic stroke
ανά: Bahador Asadi, κ.ά.
Έκδοση: (2013-01-01)

Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis.
ανά: Mengozzi, M, κ.ά.
Έκδοση: (2008)

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.
ανά: Cesca, M, κ.ά.
Έκδοση: (2009)

Erythropoietin Nanobots: Their Feasibility for the Controlled Release of Erythropoietin and Their Neuroprotective Bioequivalence in Central Nervous System Injury
ανά: Thi Huong Le, κ.ά.
Έκδοση: (2022-03-01)

Neuroprotective effects of erythropoietin on rat retinas subjected to oligemia
ανά: Litia Alves de Carvalho, κ.ά.
Έκδοση: (2018-04-01)

Neuroprotective mechanisms of erythropoietin in a rat stroke model
ανά: Juenemann Martin, κ.ά.
Έκδοση: (2020-05-01)

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders
ανά: Khalil Ghasemi Falavarjani, κ.ά.
Έκδοση: (2011-01-01)

Erythropoietin as a possible neuroprotective agent in patients with schizophrenia
ανά: George E. Barreto
Έκδοση: (2015-02-01)

Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor
ανά: Ilaria Cervellini, κ.ά.
Έκδοση: (2013-06-01)

Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats
ανά: Annalisa Canta, κ.ά.
Έκδοση: (2022-12-01)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
ανά: Federica Rey, κ.ά.
Έκδοση: (2021-01-01)

Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
ανά: Bongki Cho, κ.ά.
Έκδοση: (2022-02-01)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
ανά: M. Moransard, κ.ά.
Έκδοση: (2017-10-01)

Neuroprotective effect of erythropoietin on anesthesia-induced neurotoxicity through the modulation of autophagy in
ανά: Bon-Wook Koo, κ.ά.
Έκδοση: (2024-06-01)

Endogenous neuroprotection during focal brain ischemia in rats: erythropoietin, ischemic pre- and postconditioning
ανά: A. A. Shmonin, κ.ά.
Έκδοση: (2017-02-01)

Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
ανά: Alberto Zambelli, κ.ά.
Έκδοση: (2023-01-01)

Diffusion Tensor Imaging Changes Do Not Affect Long-Term Neurodevelopment following Early Erythropoietin among Extremely Preterm Infants in the Preterm Erythropoietin Neuroprotection Trial
ανά: Janessa B. Law, κ.ά.
Έκδοση: (2021-10-01)

Mission Planning for the Estimation of the Field Coverage of Unmanned Aerial Systems in Monitoring Mission in Precision Farming
ανά: G. Ristorto, κ.ά.
Έκδοση: (2017-06-01)

Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases
ανά: Federica Rey, κ.ά.
Έκδοση: (2019-08-01)

Erythropoietin administration exerted neuroprotective effects against cardiac ischemia/reperfusion injury
ανά: Titikorn Chunchai, κ.ά.
Έκδοση: (2022-01-01)

Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus
ανά: Jérémie Nadam, κ.ά.
Έκδοση: (2007-02-01)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
ανά: Carlos M. Galmarini, κ.ά.
Έκδοση: (2014-01-01)

Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke.
ανά: Mengozzi, M, κ.ά.
Έκδοση: (2012)

The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma
ανά: Marta Cesca, κ.ά.
Έκδοση: (2009-11-01)

Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial
ανά: Thomas R. Wood, κ.ά.
Έκδοση: (2021-10-01)

Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition
ανά: Chia-Lin Wu, κ.ά.
Έκδοση: (2010-10-01)